Aim Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with
acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage …

Objectives: We sought to assess the efficacy and safety of thrombolytic therapy in patients
with an acute pulmonary embolism (PE). Background: Thrombolytic therapy is approved for …

Background—Randomized trials and meta-analyses have reached conflicting conclusions
about the role of thrombolytic therapy for the treatment of acute pulmonary embolism …

Pulmonary embolism is a prevalent condition that may account for> 300,000 deaths
annually in the United States alone. Although thrombolytics have been studied as a …

Background In patients with acute pulmonary embolism, thrombolysis results in a more rapid
resolution of pulmonary emboli than heparin treatment. Whether this advantage results in an …

Pulmonary embolism (PE) is a common disorder that is accompanied by significant
morbidity and mortality. Although anticoagulation is the standard treatment for PE …

Background Thrombolytic therapy is usually reserved for patients with clinically serious or
massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may …

Recent guidelines recommend bolus-dose alteplase for treating massive pulmonary
embolism (PE). However, the safest and most effective treatment is as yet unknown. In the …

Importance Thrombolytic therapy may be beneficial in the treatment of some patients with
pulmonary embolism. To date, no analysis has had adequate statistical power to determine …

Background Thrombolytic treatment has been shown to accelerate resolution of major
pulmonary embolism and lead to a rapid improvement of right-side hemodynamics …